Neurology
News
What to know about newly approved Alzheimer’s drug
The drug has shown moderate positive effects in clinical trials in slowing early...
News
FDA approves second antiamyloid for Alzheimer’s disease
Like its controversial cousin aducanumab, lecanemab was approved under the FDA’s accelerated approval pathway.
News
FDA considers regulating CBD products
The products can have drug-like effects on the body and contain CBD (cannabidiol) and THC (tetrahydrocannabinol).
From the Journals
Strong link between muscle strength, mobility, and brain health
“The implication is that muscular strength and mobility influence brain health.”
News from the FDA/CDC
Alzheimer’s Association to CMS: Ditch restraints on amyloid drugs
The CMS coverage restrictions for anti-amyloid drugs were finalized in April on the...
From the Journals
Annual U.S. Parkinson’s disease incidence 50% higher than earlier estimates
About 60,000-90,000 individuals older than 45 years are estimated to be diagnosed with Parkinson’s disease each year.
Conference Coverage
Antipsychotic shows benefit for Alzheimer’s agitation
Currently, there’s no Food and Drug Administration–approved treatment for agitation in AD.
From the Journals
Noninvasive laser therapy tied to improved short-term memory
Patients with attention-related conditions ‘could benefit from this type of treatment,’ expert says.
Conference Coverage
‘Striking’ rate of mental health comorbidities in epilepsy
“We hope these results inspire epileptologists and neurologists to both recognize and screen ... adolescent patients.”
Conference Coverage
SSRI tied to improved cognition in comorbid depression, dementia
Evidence suggests the drug’s receptor targets “have the potential to modulate neurotransmitter systems that are essential for regulation of...
From the Journals
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...